Squarepoint’s Select Medical SEM Stock Holding History

Squarepoint’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$291K	Sell	17,607 -253,145	-93%	-$4.17M	﹤0.01%	3828
2026 Q1	$4.41M	Buy	270,752 +228,181	+536%	+$3.57M	0.01%	1598
2025 Q4	$632K	Buy	+42,571	New	+$602K	﹤0.01%	3013
2025 Q3	–	Sell	-61,295	Closed	-$930K	–	4924
2025 Q2	$930K	Sell	61,295 -147,232	-71%	-$2.3M	﹤0.01%	2725
2025 Q1	$3.48M	Sell	208,527 -34,229	-14%	-$630K	﹤0.01%	1677
2024 Q4	$4.58M	Buy	242,756 +162,341	+202%	+$3.13M	﹤0.01%	1715
2024 Q3	$1.51M	Buy	+80,415	New	+$1.54M	﹤0.01%	2281
2023 Q4	–	Sell	-77,445	Closed	-$1.05M	–	4444
2023 Q3	$1.05M	Buy	+77,445	New	+$1.2M	﹤0.01%	2283
2023 Q2	–	Sell	-37,894	Closed	-$528K	–	3950
2023 Q1	$528K	Sell	37,894 -107,913	-74%	-$1.59M	﹤0.01%	2266
2022 Q4	$1.95M	Buy	145,807 +64,180	+79%	+$830K	0.01%	1374
2022 Q3	$972K	Buy	+81,627	New	+$1.16M	﹤0.01%	1793
2022 Q2	–	Sell	-105,397	Closed	-$1.36M	–	3316
2022 Q1	$1.36M	Buy	105,397 +74,493	+241%	+$984K	0.01%	1397
2021 Q4	$490K	Sell	30,904 -89,704	-74%	-$1.53M	﹤0.01%	2157
2021 Q3	$2.35M	Sell	120,608 -90,928	-43%	-$1.8M	0.01%	1126
2021 Q2	$4.82M	Buy	211,536 +197,297	+1,386%	+$4.09M	0.02%	740
2021 Q1	$262K	Sell	14,239 -17,764	-56%	-$291K	﹤0.01%	2509
2020 Q4	$477K	Buy	+32,003	New	+$418K	﹤0.01%	1847
2020 Q3	–	Sell	-280,317	Closed	-$2.23M	–	2803
2020 Q2	$2.23M	Buy	280,317 +41,988	+18%	+$348K	0.04%	598
2020 Q1	$1.93M	Buy	+238,329	New	+$2.83M	0.05%	452
2019 Q3	–	Sell	-87,173	Closed	-$745K	–	2642
2019 Q2	$745K	Sell	87,173 -34,794	-29%	-$275K	0.01%	1436
2019 Q1	$926K	Buy	+121,967	New	+$981K	0.01%	1149
2018 Q1	–	Sell	-54,993	Closed	-$523K	–	2095
2017 Q4	$523K	Buy	+54,993	New	+$526K	0.01%	1177
2017 Q2	–	Sell	-34,954	Closed	-$251K	–	1782
2017 Q1	$251K	Buy	+34,954	New	+$253K	0.01%	1177
2016 Q3	–	Sell	-34,776	Closed	-$204K	–	1233
2016 Q2	$204K	Sell	34,776 -48,094	-58%	-$319K	0.01%	889
2016 Q1	$527K	Buy	82,870 +56,756	+217%	+$304K	0.04%	600
2015 Q4	$168K	Buy	+26,114	New	+$163K	0.02%	1045

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Squarepoint's SEM Position: Q2 2026 in Review

Squarepoint reduced its Select Medical (SEM) stake by 93% in Q2 2026, selling an estimated $4.17M and leaving 17,607 shares worth $291K. The position accounts for ﹤0.01% of the portfolio, ranked #3828.

Squarepoint first reported a position in SEM in Q4 2015 and has held it in 26 quarters since. The position peaked at $4.82M in Q2 2021. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

Squarepoint held 17,607 shares of Select Medical worth $291K as of Q2 2026.
Squarepoint sold 253,145 Select Medical shares in Q2 2026, an estimated $4.17M.
Select Medical made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3828 holding.
Squarepoint first reported a position in Select Medical in Q4 2015 and has held it in 26 quarters since.
Squarepoint's Select Medical position peaked at $4.82M in Q2 2021.
238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.